Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Rapid Turnover of Extracellular Signal-Regulated Kinase 3 by the Ubiquitin-Proteasome Pathway Defines a Novel Paradigm of Mitogen-Activated Protein Kinase Regulation during Cellular Differentiation
Philippe Coulombe,1,2 Geneviève Rodier,1 Stéphane Pelletier,1,3 Johanne Pellerin,1 and Sylvain Meloche1,2,3*
Institut de Recherches Cliniques de Montréal,1
Departments of Molecular Biology,2
Pharmacology, Université de Montréal, Montreal, Quebec H2W 1R7, Canada3
Received for publication 23 September 2002.
Revision received 6 November 2002.
Accepted for publication 31 March 2003.
Abstract:
Mitogen-activated protein (MAP) kinases are stable enzymes thatare mainly regulated by phosphorylation and subcellular targeting.Here we report that extracellular signal-regulated kinase 3(ERK3), unlike other MAP kinases, is an unstable protein thatis constitutively degraded in proliferating cells with a half-lifeof 30 min. The proteolysis of ERK3 is executed by the proteasomeand requires ubiquitination of the protein. Contrary to otherprotein kinases, the catalytic activity of ERK3 is not responsiblefor its short half-life. Instead, analysis of ERK1/ERK3 chimerasrevealed the presence of two destabilization regions (NDR1 and-2) in the N-terminal lobe of the ERK3 kinase domain that areboth necessary and sufficient to target ERK3 and heterologousproteins for proteasomal degradation. To assess the physiologicalrelevance of the rapid turnover of ERK3, we monitored the expressionof the kinase in different cellular models of differentiation.We observed that ERK3 markedly accumulates during differentiationof PC12 and C2C12 cells into the neuronal and muscle lineage,respectively. The accumulation of ERK3 during myogenic differentiationis associated with the time-dependent stabilization of the protein.Terminal skeletal muscle differentiation is accompanied by cellcycle withdrawal. Interestingly, we found that expression ofstabilized forms of ERK3 causes G1 arrest in NIH 3T3 cells.We propose that ERK3 biological activity is regulated by itscellular abundance through the control of protein stability.
* Corresponding author. Mailing address: Institut de Recherches Cliniques de Montréal, 110 Pine Ave., West, Montreal, Quebec H2W 1R7, Canada. Phone: (514) 987-5783. Fax: (514) 987-5536. E-mail: melochs{at}ircm.qc.ca.
The editors suggest the following Related Resources on Science sites:
Identification and Proteomic Analysis of Distinct UBE3A/E6AP Protein Complexes.
G. Martinez-Noel, J. T. Galligan, M. E. Sowa, V. Arndt, T. M. Overton, J. W. Harper, and P. M. Howley (2012)
Mol. Cell. Biol.
32, 3095-3106
|Abstract »|Full Text »|PDF »
Iron Regulatory Protein 2 Turnover through a Nonproteasomal Pathway.
A. H. K. Chang, J. Jeong, and R. L. Levine (2011)
J. Biol. Chem.
286, 23698-23707
|Abstract »|Full Text »|PDF »
Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases.
Activation Loop Phosphorylation of ERK3/ERK4 by Group I p21-activated Kinases (PAKs) Defines a Novel PAK-ERK3/4-MAPK-activated Protein Kinase 5 Signaling Pathway.
P. Deleris, M. Trost, I. Topisirovic, P.-L. Tanguay, K. L. B. Borden, P. Thibault, and S. Meloche (2011)
J. Biol. Chem.
286, 6470-6478
|Abstract »|Full Text »|PDF »
Targeted Inactivation of Mapk4 in Mice Reveals Specific Nonredundant Functions of Erk3/Erk4 Subfamily Mitogen-Activated Protein Kinases.
J. Rousseau, S. Klinger, A. Rachalski, B. Turgeon, P. Deleris, E. Vigneault, J.-F. Poirier-Heon, M. A. Davoli, N. Mechawar, S. El Mestikawy, et al. (2010)
Mol. Cell. Biol.
30, 5752-5763
|Abstract »|Full Text »|PDF »
Uncoupling of Expression of an Intronic MicroRNA and Its Myosin Host Gene by Exon Skipping.
M. L. Bell, M. Buvoli, and L. A. Leinwand (2010)
Mol. Cell. Biol.
30, 1937-1945
|Abstract »|Full Text »|PDF »
Loss of Erk3 function in mice leads to intrauterine growth restriction, pulmonary immaturity, and neonatal lethality.
S. Klinger, B. Turgeon, K. Levesque, G. A. Wood, K. M. Aagaard-Tillery, and S. Meloche (2009)
PNAS
106, 16710-16715
|Abstract »|Full Text »|PDF »
Docking of PRAK/MK5 to the Atypical MAPKs ERK3 and ERK4 Defines a Novel MAPK Interaction Motif.
E. Aberg, K. M. Torgersen, B. Johansen, S. M. Keyse, M. Perander, and O.-M. Seternes (2009)
J. Biol. Chem.
284, 19392-19401
|Abstract »|Full Text »|PDF »
Participation of the Human Sperm Proteasome in the Capacitation Process and Its Regulation by Protein Kinase A and Tyrosine Kinase.
Regulation of MAPK-activated Protein Kinase 5 Activity and Subcellular Localization by the Atypical MAPK ERK4/MAPK4.
E. Aberg, M. Perander, B. Johansen, C. Julien, S. Meloche, S. M. Keyse, and O.-M. Seternes (2006)
J. Biol. Chem.
281, 35499-35510
|Abstract »|Full Text »|PDF »
Characterization of the Atypical MAPK ERK4 and Its Activation of the MAPK-activated Protein Kinase MK5.
S. Kant, S. Schumacher, M. K. Singh, A. Kispert, A. Kotlyarov, and M. Gaestel (2006)
J. Biol. Chem.
281, 35511-35519
|Abstract »|Full Text »|PDF »
Involvement of the I{kappa}B Kinase (IKK)-Related Kinases Tank-Binding Kinase 1/IKKi and Cullin-Based Ubiquitin Ligases in IFN Regulatory Factor-3 Degradation.
A. Bibeau-Poirier, S.-P. Gravel, J.-F. Clement, S. Rolland, G. Rodier, P. Coulombe, J. Hiscott, N. Grandvaux, S. Meloche, and M. J. Servant (2006)
J. Immunol.
177, 5059-5067
|Abstract »|Full Text »|PDF »
Ubiquitin-Proteasome-mediated Degradation, Intracellular Localization, and Protein Synthesis of MyoD and Id1 during Muscle Differentiation.
L. Sun, J. S. Trausch-Azar, A. Ciechanover, and A. L. Schwartz (2005)
J. Biol. Chem.
280, 26448-26456
|Abstract »|Full Text »|PDF »